B Cell Alloimmunity
B Cell Alloimmunity is a pathological immune mechanism, within the broader class of alloimmune responses, distinguished by the activation and differentiation of B lymphocytes into alloantibody-producing plasma cells that specifically target donor major or minor histocompatibility antigens following transplantation.
115
Publications
6.4K
Citations
547
Authors
171
Institutions
Publications per year
2017–2026
5
Parents
115
Two levels of help for B cell alloantibody production.
David Steele, Terri M. Laufer, S T Smiley et al. · The Journal of Experimental Medicine · 1996 · 214 citations · Full text
1–5 of 115
547
5
h-index
5
h-index
Memorial Sloan Kettering Cancer Center, United States
4 publications · 314 citations
4
h-index
4
h-index
3
h-index
1–5 of 547
171
Harvard University
Cambridge, United States
11 h-index
57 publications
2.8K citations
National Cancer Institute
Bethesda, United States
9 h-index
29 publications
1.5K citations
Massachusetts General Hospital
Boston, United States
9 h-index
36 publications
2.6K citations
National Institutes of Health
Bethesda, United States
8 h-index
26 publications
1.3K citations
Memorial Sloan Kettering Cancer Center
New York, United States
6 h-index
15 publications
701 citations
Yale University
New Haven, United States
5 h-index
8 publications
721 citations
National Institute of Allergy and Infectious Diseases
Bethesda, United States
5 h-index
21 publications
595 citations

Brigham and Women's Hospital
Boston, United States
4 h-index
21 publications
908 citations
1–8 of 171
JI · 20 publications · 575 citations
15
h-index
10 publications · 675 citations
10
h-index
Repository · 8 publications · 251 citations
8
h-index
7 publications · 143 citations
7
h-index
6 publications · 392 citations
6
h-index
1–5